TIMP-1 Alters-Susceptibility to Carcinogenesis

Cancer Research

Volumn 64, Issue 3, 2004, Pages 952-961

  Rhee, Jin Sae ^a   Diaz, Robert ^a   Korets, Lidiya ^a   Hodgson, J Graeme ^b   Coussens, Lisa M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; KERATIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARCINOMA; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; EPITHELIUM; HUMAN; KERATINOCYTE; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; STROMA; TRANSGENIC MOUSE; TUMOR PROMOTION; WART VIRUS;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; PAPILLOMAVIRIDAE; RNA, MESSENGER; SKIN NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0842325794     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2445     Document Type: Article

References (93)

1. Woessner, J. F., and Nagase, H. Matrix Metalloproteinases and TIMPs. Oxford, UK: Oxford University Press, 2000.
2. Brew, K., Dinakarpandian, D., and Nagase, H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta, 1477: 267-283, 2000.
3. Fassina, G., Ferrari, N., Brigati, C., Benelli, R., Santi, L., Noonan, D. M., and Albini, A. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin. Exp. Metastasis, 18: 111-120, 2000.
4. Lafleur, M. A., Handsley, M. M., and Edwards, D. R. Metalloproteinases and their inhibitors in angiogenesis. Exp. Rev. Mol. Med., 5: 1-39, 2003.
5. Docherty, A. J., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J., Murphy, G., and Reynolds, J. J. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (Lond.), 318: 66-69, 1985.
6. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., and Iwata, K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett., 298: 29-32, 1992.
7. Bertaux, B., Hornebeck, W., Eisen, A. Z., and Dubertret, L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Investig. Dermatol., 97: 679-685, 1991.
8. Avalos, B. R., Kaufman, S. E., Tomonaga, M., Williams, R. E., Golde, D. W., and Gasson, J. C. K562 cells produce and respond to human erythroid-potentiating activity. Blood 71: 1720-1725, 1988.
9. Chesler L., Golde, D. W., Bersch, N., and Johnson, M. D. Metalloproteinase inhibition erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood, 86: 4506-4515, 1995.
10. Yamada, E., Tobe, T., Yamada, H., Okamoto, N., Zack, D. J., Werb, Z., Soloway, P. D., and Campochiaro, P. A. TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol. Histopathol., 16: 87-97, 2001.
11. Thorgeirsson, U. P., Yoshiji, H., Sinha, C. C., and Gomez, D. E. Breast cancer; tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis. In Vivo, 10: 137-144, 1996.
12. Guedez, L., Mansoor, A., Birkedal-Hansen, B., Lim, M. S., Fukushima, P., Venzon, D., Stetler-Stevenson, W. G., and Stetler-Stevenson, M. Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood, 97: 1796-1802, 2001.
13. Apparailly, F., Noel, D., Millet, V., Baker, A. H., Lisignoli, G., Jacquet, C., Kaiser, M. J., Sany, J., and Jorgensen, C. Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis. Arthritis Rheum., 44: 1444-1454, 2001.
14. Kruger, A., Sanchez-Sweatman, O. H., Martin, D. C., Fata, J. E., Ho, A. T., Orr, F. W., Ruther, U., and Khokha, R. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene, 16: 2419-2423, 1998.
15. Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., and Albini, A. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer, 75: 246-253, 1998.
16. Smith, M. R., Kung, H. Durum, S. K., Colburn, N. H., and Sun, Y. TIMP-3 induces cell, death by stabilizing TNF-á receptors on the surface of human colon carcinoma cells. Cytokine, 9: 770-780, 1997.
17. Jiang, Y., Wang, M., Celiker, M. Y., Liu, Y. E., Sang, Q. X., Goldberg, I. D., and Shi, Y. E. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res., 61: 2365-2370, 2001.
18. Curran, S., and Murray, G. I. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol., 189: 300-308, 1999.
19. Martin, D. C., Sanchez-Sweatman, O. H., Ho, A. T., Inderdeo, D. S., Tsao, M. S., and Khokha, R. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab. Invest., 79: 225-234, 1999.
20. Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J. P., Gray, J. W., Pinkel, D., Bissell, M. J., and Werb, Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98: 137-146, 1999.
21. Noritake, H., Miyamori, H., Goto, C., Seiki, M., and Sato, H. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src. Clin. Exp. Metastasis, 17: 105-110, 1999.
22. Kawamata, H., Kawai, K., Kameyama, S., Johnson, M. D., Stetler-Stevenson, W. G., and Oyasu, R. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int. J. Cancer, 63: 680-687, 1995.
23. Watanabe, M., Takahashi, Y., Ohta, T., Mai, M., Sasaki, T., and Seiki, M. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer (Phila.), 77: 1676-1680, 1996.
24. Heppner-Goss, K. J., Brown, P. D., and Matrisian, L. M. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. Int. J. Cancer, 78: 629-635, 1998.
25. Coussens, L. M., Hanahan, D., and Arbeit, J. M. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol., 149: 1899-1917, 1996.
26. Coussens, L. M., Tinkle, C. L., Hanahan, D., and Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103: 481-490, 2000.
27. van Kempen, L. C. L., Rhee, J. S., Dehne, K., Lee, J., Edwards, D. R., and Coussens, L. M. Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differentiation, 70: 501-623, 2002.
28. Arbeit, J. M., Munger, K., Howley, P. M., and Hanahan, D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J. Virol., 68: 4358-4368, 1994.
29. + T cells. J. Exp. Med., 197: 1017-1028, 2003.
30. Alexander, C. M., Howard, E. W., Bissell, M. J., and Werb, Z. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J. Cell Biol., 135: 1669-1677, 1996.
31. Chomczynski, P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques, 15: 532-534, 536-537, 1993.
32. Edwards, D. R. The tissue inhibitors of metalloproteinases (TIMPs). In: N. J. Clendeninn and K. Appelt (eds.), Matrix Metalloproteinase Inhibitors in Cancer Therapy, pp. 67-84. Totowa, NJ: Humana Press, 2000.
33. Shimizu, S., Malik, K., Sejima, H., Kishi, J., Hayakawa, T., and Koiwai, O. Cloning and sequencing of the cDNA encoding a mouse tissue inhibitor of metalloproteinase-2. Gene, 114: 291-292, 1992.
34. Apte, S. S., Hayashi, K., Seldin, M. F., Mattei, M. G., Hayashi, M., and Olsen, B. R. Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, an is located on mouse chromosome 10. Dev. Dyn., 200: 177-197, 1994.
35. Leco, K. J., Apte, S. S., Taniguchi, G. T., Hawkes, S. P., Khokha, R., Schultz, G. A., and Edwards, D. R. Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett., 401: 213-217, 1997.
36. Herron, G. S., Werb, Z., Dwyer, K., and Banda, M. J. Secretion of metalloproteinases by stimulated capillary endothelial cells. 1. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem., 261: 2810-2813, 1986.
37. Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., and Werb, Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. 11. Expression of genase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem., 261: 2814-2818, 1986.
38. Canham, P. B., Finlay, H. M., Kiernan, J. A., and Ferguson, G. G. Layered structure of saccular aneurysms assessed by collagen birefringence. Neurol. Res., 21: 618-626, 1999.
39. Junqueira, L. C., Bignolas, G., and Brentani, R. R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J., 11: 447-455, 1979.
40. Puchtler, H., Waldrop, F. S., and Valentine, L. S. Polarization microscopic studies of connective tissue stained with pisco-sirius red FBA. Beitr. Pathol., 150: 174-187, 1973.
41. Junqueira, L. C., Cossermelli, W., and Brentani, R. Differential staining of collagens type 1, 11 and 111 by Sirius Red and polarization microscopy. Arch. Histol. Jpn., 41: 267-274, 1978.
42. Malkusch, W., Rehn, B., and Bruch, J. Advantages of Sirius Red staining for quantitative morphometric collagen measurements in lungs. Exp. Lung Res., 21: 67-77, 1995.
43. Polette, M., Clavel, C., Birembaut, P., and De Clerck, Y. A. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol. Res. Pract., 189: 1052-1057, 1993.
44. Charous, S. J., Stricklin, G. P., Nanney, L. B., Netterville, J. L., and Burkt, B. B. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann. Otol. Rhinol. Laryngol., 106: 271-278, 1997.
45. Vaalamo M., Leivo, T., and Saarialho-Kere, U. Differential tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum. Pathol., 30: 795-802, 1999.
46. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
47. Buisson-Legendre, N., Emonard, H., Bernard, P., and Hornebeck, W. Relationship between cell-associated matrix metalloproteinase 9 and psoriatic keratinocyte growth. J. Investig. Dermatol., 115: 213-218, 2000.
48. Guedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A., and Stetler-Stevenson, M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Investig., 102: 2002-2010, 1998.
49. Li, G., Fridman, R., and Kim, H. R. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res., 59: 6267-6275, 1999.
50. Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., and Hanahan, D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev., 13: 1382-1397, 1999.
51. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W. L., Chen, C., Zhai, Y., Dairkee, S. H., Ljung, B. M., Gray, J. W., and Albertson, D. G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 20: 207-211, 1998.
52. Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., Nowak, N., Albertson, D. G., Pinkel, D., Collins, C., Hanahan, D., and Gray, J. W. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet., 29: 459-464, 2001.
53. Snidjers, A. M., Nowee, M., Fridlyand, J., Piek, J., Dorsman, J. C., Pinkel, D., van Diest, P. J., Verheijen, J. H., and Albertson, D. G. Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene 22: 4281-4286, 2003.
54. Brinckerhoff, C. E., and Matrisian, L. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev., 3: 207-214, 2002.
55. Ala-aho, R., Johansson, N., Grenman, R., Fusenig, N. E., Lopez-Otin, C., and Kahari, V. M. Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-ã is associated with activation of extracellular signal-regulated kinase-1, 2 and STAT1. Oncogene, 19: 248-257, 2000.
56. Deryugina, E. I., Luo, G. X., Reisfeld, R. A., Bourdon, M. A., and Strongin, A. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res., 17: 3201-3210, 1997.
57. Egeblad, M., and Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2: 161-174, 2002.
58. DeClerck, Y. A., and Imren, S. Protease inhibitors: role and potential therapeutic use in human cancer. Eur. J. Cancer, 14: 2170-2180, 1994.
59. Montgomery, A. M., Mueller, B. M., Reisfeld, R. A., Taylor, S. M., and DeClerck, Y. A. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res., 54: 5467-5473, 1994.
60. Khokha, R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J. Natl. Cancer Inst. (Bethesda), 86: 299-304, 1994.
61. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., and Groom, A. C. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res., 54: 4791-4797, 1994.
62. Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S., and Carmichael, D. F. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res., 48: 5539-5545, 1988.
63. Alvarez, O. A., Carmichael, D. F., and DeClerck, Y. A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst., 82: 589-595, 1990.
64. Buck, T. B., Yoshiji, H., Harris, S. R., Bunce, O. R., and Thorgeirsson, U. P. The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice. Ann. N. Y. Acad. Sci., 878: 732-735, 1999.
65. Martin, D. C., Rüther, U., Sanchez-Sweatman, O. H., Orr, F. W., and Khokha, R. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene, 13: 569-576, 1996.
66. Sternlicht, M. D., Bissell, M. J., and Werb, Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene, 19: 1102-1113, 2000.
67. Murashige, M., Miyahara, M., Shiraishi, N., Saito, T., Kohno, K., and Kobayashi, M. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn. J. Clin. Oncol., 26: 303-309, 1996.
68. Schrohl, A. S., Christensen, I. J., Pedersen, A. N., Jensen, V., Mouridsen, H., Murphy, G., Foekens, J. A., Brunner, N., and Holten-Andersen, M. N. Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer. Mol. Cell. Proteomics, 2: 164-172, 2003.
69. Whittaker, M., Floyd, C. D., Brown, P., and Gearing, A. J. Design and therapeutic application of matrix metalloproteinase inhibitors. Chem. Rev., 99: 2735-2776, 1999.
70. Hidalgo, M., and Eckhardt, S. G. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl. Cancer Inst. (Bethesda), 93: 178-193, 2001.
71. Zucker, S., Cao, J., and Chen, W. T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene, 19: 6642-6650, 2000.
72. Coussens, L. M., B. Fingleton, B., and Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (Wash. DC), 295: 2387-2392, 2002.
73. Wang, X., Fu, X., Brown, P. D., Crimmin, M. J., and Hoffman, R. M. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res., 54: 4726-4728, 1994.
74. Huang, W., Suzuki, K., Nagase, H., Arumugam, S., Van Doren, S. R., and Brew, K. Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield in E. coli. FEBS Lett., 384: 155-161, 1996.
75. Bergers, G., Javaherian, K., Lo, K. M., Folkman, J., and Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science (Wash. DC), 284: 808-812, 1999.
76. Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L., and Matrisian, L. M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA, 94: 1402-1407, 1997.
77. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol., 2: 737-744, 2000.
78. Martin, D. C., Fowlkes, J. L., Babic, B., and Khokha, R. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. J. Cell Biol., 146: 881-892, 1999.
79. Yoshiji, H., Harris, S. R., Raso, E., Gomez, D. E., Lindsay, C. K., Shibuya, M., Sinha, C. C., and Thorgeirsson, U. P. Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. Int. J. Cancer, 75: 81-87, 1998.
80. Guedez, L., McMarlin, A. J., Kingma, D. W., Bennett, T. A., Stetler-Stevenson, M., and Stetler-Stevenson, W. G. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Am. J. Pathol., 158: 1207-1215, 2001.
81. Doxsey, S. Duplicating dangerously: linking centrosome duplication and aneuploidy. Mol. Cell., 10: 439-440, 2002.
82. Jallepalli, P. V., and Lengauer, C. Chromosome segregation and cancer: cutting through the mystery. Nat. Rev. Cancer, 1: 109-117, 2001.
83. D'Assoro, A. B., Lingle, W. L., and Salisbury, J. L. Centrosome amplification and the development of cancer. Oncogene. 21: 6146-6153, 2002.
84. Kramer, A., Neben, K., and Ho, A. D. Centrosome replication, genomic instability and cancer. Leukemia, 16: 767-775, 2002.
85. Duensing, S., and Munger, K. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene, 21: 6241-6248, 2002.
86. Doak, S. H., Jenkins, G. J., Parry, E. M., D'Souza, F. R., Griffiths, A. P., Toffazal, N., Shah, V., Baxter, J. N., and Parry, J. M. Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus. Gut, 52: 623-628, 2003.
87. Duensing, S., and Munger, K. Centrosomes, genomic instability, and cervical carcinogenesis. Crit. Rev. Eukaryot. Gene. Expr., 13: 9-23, 2003.
88. Sugai, T., Takahashi, H., Habano, W., Nakamura, S., Sato, K., Orii, S., and Suzuki, K. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas. J. Pathol., 200: 168-176, 2003.
89. Bockmuhl, U., and Petersen, I. DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch., 441: 541-550, 2002.
90. Sudbo, J., and Reith, A. Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals. J. Oral. Pathol. Med., 32: 63-70, 2003.
91. Zhao, W. Q., Li, H., Yamashita, K., Guo, X. K., Hoshino, T., Yoshida, S., Shinya, T., and Hayakawa, T. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J. Cell Sci., 111 (Pt 9): 1147-1153, 1998.
92. Ritter, L. M., Garfield, S. H., and Thorgeirsson, U. P. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem. Biophys. Res. Commun., 257: 494-499, 1999.
93. Soloway, P. D., Alexander, C. M., Werb, Z., and Jaenisch, R. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. Oncogene, 13: 2307-2314, 1996.